In cervical cancer, GCN5 increases the binding of GCN5 to the E2F1 promoter region by acetylating c‐myc and increases the degree of histone acetylation in this region, accelerating E2F1 expression and cell cycle progression.218. Here, KAT2A is linked to cervical cancer.